Boston Therapeutics, Inc.
Boston Therapeutics, Inc. (BTHE) is a publicly traded company in the Unknown sector. Across all available filings, 7 corporate insiders have executed 43 transactions totaling $722.6K, demonstrating a bullish sentiment with $562.6K in net insider flow. The most recent transaction on May 15, 2015 involved a purchase of 1,000 shares valued at $150.
BTHE Insider Activity Summary
Who Is Buying BTHE Stock?
No significant insider buying has been recorded for BTHE in the recent period.
Who Is Selling BTHE Stock?
No significant insider selling has been recorded for BTHE in the recent period.
Is Boston Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for BTHE is bullish with an Insider Alignment Score of 89/100 and a net flow of $562.6K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
BTHE Frequently Asked Questions
Understanding BTHE Insider Activity
Insider trading at Boston Therapeutics, Inc. (BTHE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 7 insiders are actively trading BTHE stock, having executed 43 transactions in the past 90 days. The most active insider is Jonathan B. Rome (Executive), who has made 1 transactions totaling $625.0K.
Related Tools
Track Boston Therapeutics, Inc. Insider Activity
Get notified when executives and directors at BTHE file new Form 4 transactions